Improve early-stage decision-making, optimize lifecycle management, and tailor product plans to ensure the successful commercialization of new drugs

In a time where a pandemic has shaken up all previous assumptions about the life science industry, typical new product planning timelines and processes have been extremely impacted. This new virtual world has forced us to quickly adapt to new implications that have both accelerated and hindered development due to changing competitive landscapes, budgets, and engagement strategies. Informed decision-making is pivotal to the successful development and commercialization of a new drug, and companies need to have a streamlined process for gaining strategic input from multiple functional teams along a product’s development cycle to help navigate the competitive landscape.

The 5th New Product Planning Summit serves as an educational platform for new product development, commercial planning, brand strategy, and marketing professionals to discuss how to utilize tools and resources to optimize early decision-making, collaborate with cross-functional partners to guide product development, and leverage key insights to tailor a product plan to ensure the successful launch of a new product.

WHAT’S NEW

As an added benefit, attendees will get an additional two days of content with a new perspective – Launch Readiness. To learn about what you will hear from your medical affairs colleagues on launch excellence, click the button below.

February 4–5, 2021

“Great way to facilitate networking, small group discussion and learning from other in similar roles.” — SANOFI GENZYME

"The panel had a great perspective, was engaging with the audience and brought a fresh perspective to the day.” — LEO PHARMA

"A very practical approach to using claims data analyses to address complex questions.” — GENENTECH